Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
Endovascular Infusion of Lidocaine and Steroids in the Middle Meningeal Artery for Pain Management in Spontaneous Subarachnoid Hemorrhage Patients
The University of Texas Medical Branch, Galveston
15 participants
Jan 2, 2026
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
Eligibility
Inclusion Criteria3
- Age ≥18 years.
- Diagnosed with aneurysmal SAH, Hunt and Hess Grades 1-2.
- Consent to study procedures and follow-up evaluations.
Exclusion Criteria8
- Known allergies to lidocaine or steroids.
- Arteriovenous malformations.
- Dural Arteriovenous Fistulas.
- Other significant intracranial pathologies.
- Hemodynamic instability preventing safe intervention.
- Previous MMA interventions.
- Previous craniotomies or need for craniotomy.
- Need for external ventricular drain.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The participants will receive 50 mg of lidocaine.
The participants will receive 50 mg of lidocaine and 10 mg of dexamethasone one after the other.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07294118